Background
==========

Because industrialized countries are experiencing an aging population, the age of patients necessitating cardiac surgery is steadily rising. According to the registry of the German Society for Thoracic and Cardiovascular Surgery, more than 8.4% of patients undergoing cardiac surgical procedures in 2005 were older than 80 years, compared to 2.7% ten years ago \[[@B1]\]. It was shown that these high risk elderly patients derive benefit from coronary revascularization, aortic as well as mitral valve surgery, and combined procedures \[[@B2]-[@B4]\].

Atrial fibrillation (AF), a significant factor for stroke and premature death, is the most frequent sustained atrial arrhythmia \[[@B5]\]. Because its incidence increases with age, a growing number of patients scheduled for valvular or coronary heart surgery, nowadays present AF \[[@B6],[@B7]\]. During the last decade, surgical AF treatment, initially introduced as Maze procedure \[[@B8],[@B9]\], has been developed to a less complex operation by using different technologies for tissue ablation and by focussing the lesion pattern on the left atrium \[[@B7],[@B10],[@B11]\]. AF ablation has become a frequently performed concomitant procedure in cardiac surgery with overall promising results regarding sinus rhythm (SR) restoration \[[@B7],[@B10]\].

Because the results of surgical AF treatment in octogenarians are not clear, we evaluated outcome of these patients undergoing cardiac surgery and concomitant AF ablation.

Methods
=======

Patients
--------

Between January 2003 and February 2006, a total of 200 patients (54.5% male) scheduled for cardiac surgery underwent concomitant AF ablation. The majority of patients presented with persistent/continuous AF (n = 174, 87.0%) according to established definitions \[[@B12],[@B13]\]. Out of all, 28 patients aged 80 years and older were summarized as group of octogenarians. According to age (\< 80 years versus ≥ 80 years), patients were prospectively studied. Preoperative, perioperative and follow up data were entered into an institutional database. Informed consent regarding the operation and data acquisition was obtained from all patients. For assessment of perioperative risk, logistic EuroSCORE was determined \[[@B14]\].

Surgical procedures and perioperative treatment
-----------------------------------------------

The detailed procedures of the study population are listed in Table [1](#T1){ref-type="table"}. For all procedures, standard normothermic cardiopulmonary bypass and warm antegrade blood cardioplegia were used. All patients underwent endocardial ablation of the left atrium as described in detail previously \[[@B7]\]. The left atrial appendage was oversewn only if thrombi were inside (n = 4).

###### 

Surgical procedures

                                    Overall (n = 200) % (n)   Age \< 80 yrs (n = 172) % (n)   Age ≥ 80 yrs (n = 28) % (n)
  --------------------------------- ------------------------- ------------------------------- -----------------------------
  MVP/-R                            37.5 (75)                 41.3 (71)                       14.3 (4)
   isolated                         57.3 (43)                 59.2 (42)                       25.0 (1)
   + CABG                           28.0 (21)                 25.4 (18)                       75.0 (3)
   + TVP/R/+ CABG/+ congenital      14.7 (11)                 15.5 (11)                       \-
  AVR                               34.0 (68)                 28.5 (49)                       67.8 (19)
   isolated                         58.8 (40)                 61.2 (30)                       52.6 (10)
   + CABG                           11.8 (8)                  6.1 (3)                         26.3 (5)
   + MVP/-R/+ TVP/-R/+ CABG/+ AAR   29.4 (20)                 32.6(16)                        21.1 (4)
  CABG                              28.0 (56)                 29.6 (51)                       17.8 (5)
   isolated                         98.2 (55)                 98.0 (50)                       100 (5)
   + aneurysmectomy                 1.8 (1)                   2.0 (1)                         \-
  other procedures                  0.5 (1)                   0.6 (1)                         \-
  LA reduction plasty               1.5 (3)                   1.7 (3)                         \-
  reoperation                       7.0 (14)                  7.6 (13)                        3.6 (1)
  microwave ablation                53.5 (107)                52.9 (91)                       57.1 (16)
  radiofrequency ablation           46.5 (93)                 47.1 (81)                       42.8 (12)

AAR, ascending aortic replacement, AVR, aortic valve replacement; CABG, coronary artery bypass grafting; MVP/-R, mitral valve plasty/replacement; TVP/R, tricuspid valve plasty/replacement; yrs, years

All patients were anticoagulated with heparin followed by phenprocoumon with a target INR of 2.0--3.0. After 3 months and stable sinus or atrial driven pacemaker rhythm in Holter ECG and mechanical atrial function in echocardiogram anticoagulation was ceased. Patients with mechanical valve substitutes were kept on phenprocoumon permanently (INR of 2.5--3.5 for aortic and 3.0--4.0 for mitral valve prostheses). DC shock cardioversion of early recurrent AF was performed if patient was symptomatic or hemodynamically compromised. Perioperatively, either patient\'s preoperative betablocker was continued or antiarrhythmic treatment with class III antiarrhythmic drugs (sotalol or amiodarone) was initiated. The decision was left to the discretion of the surgeon. After discharge, patient\'s general physician or cardiologist managed the anticoagulation and antiarrhythmic therapy.

Follow up
---------

Prospective follow up (FU) was performed after 3, 6, 12 months and annually thereafter. Patients were interviewed and underwent clinical examination, electrocardiography, and transthoracic echocardiography (TTE). Only in 9 patients (4.8%), who were not able to visit the clinic, interviewing was done by telephone and echocardiographic data were obtained from the referring cardiologist. Ablation was considered successful if SR was maintained with no symptomatic or documented episodes of AF or atrial flutter. Any regular atrial driven rhythm, including atrial (n = 1), atrioventricular (n = 3), or atrial triggered ventricular (n = 5) pacing, was regarded as sinus rhythm (SR).

Echocardiography
----------------

Preoperatively, before discharge and at FU, all patients underwent TTE using the HP Sonos 5500 (Hewlett Packard, Andover, Massachusetts, USA). LA and LV diameter were measured using standard techniques. LVEF was assessed by the Simpson method. For assessment of LA function the pulsed-wave signal of diastolic transmitral flow was used. Maximal flow velocities of E and A waves were measured and E/A ratio was calculated.

Statistical analysis
--------------------

Unless otherwise indicated, data are presented as mean ± standard deviation or absolute and relative frequencies. For comparison between groups, Mann-Whitney\'s U-test (continuous variables) and Fisher\'s exact test (categorical variables) were used. For comparison of FU and preoperative data within groups Wilcoxon\'s rank-sum test was applied. All tests of significance were two-tailed and a value of p \< 0.05 was considered significant. During FU, freedom from AF was calculated according to the Kaplan-Meier method. Differences were analysed by log-rank test. Statistical analysis was performed using a statistical software program (SPSS 13.0 for Windows, SPSS Inc., Chicago, Illinois, USA).

Results
=======

Patient groups
--------------

The mean age of octogenarians was 82 ± 2.4 years (range 80--89 years), whereas the mean age of younger patients was significantly lower at 68 ± 7.9 years (range 40--79 years). Baseline characteristics are presented in Table [2](#T2){ref-type="table"}. There was a higher proportion of women in octogenarians which was associated with a lower body surface area. The pattern of valvular heart disease was significantly different in both groups with respectively higher incidence of mitral valve disease in younger and aortic valve disease in older patients. There was a non-significant trend to an increased percentage of patients with a history of thrombembolic events in octogenarians. AF duration and LA size, two important AF criteria, were similar in either group, although a higher proportion of younger patients were in persistent AF. According to New York Heart Association (NYHA) functional class and EuroSCORE, older patients were significantly more compromised and exhibited a higher perioperative risk.

###### 

Baseline data

                                     Age \< 80 yrs (n = 172)   Age ≥ 80 yrs (n = 28)   p
  ------------------------- -------- ------------------------- ----------------------- ----------
  male gender               \% (n)   57.6 (99)                 35.7 (10)               0.031
  body surface area         m^2^     1.9 ± 0.22                1.8 ± 0.18              0.003
  coronary artery disease   \% (n)   45.3 (78)                 50.0 (14)               0.647
  mitral valve disease      \% (n)   50.0 (86)                 28.6 (8)                0.035
  aortic valve disease      \% (n)   28.5 (49)                 67.8 (19)               \< 0.001
  others                    \% (n)   9.3 (16)                  \-                      \-
  previous embolism         \% (n)   1.7 (3)                   7.1 (2)                 0.089
  persistent AF             \% (n)   89.0 (153)                75.0 (21)               0.042
  AF duration               months   63 ± 86.3                 48 ± 63.2               0.400
  LA diameter               mm       49 ± 8.8                  49 ± 6.1                0.954
  LVEF                               0.51 ± 0.013              0.52 ± 0.014            0.656
  LVEDD                     mm       54 ± 8.1                  49 ± 10.4               0.379
  NYHA class                         2.9 ± 0.81                3.4 ± 0.67              0.021
  logistic EuroSCORE        \%       7.4 ± 7.31                17.3 ± 10.93            \< 0.001

AF, atrial fibrillation; LA, left atrial; LVEDD, left ventricular enddiastolic diameter; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; yrs, years

Procedural outcome
------------------

In octogenarians and younger patients, there was no difference in aortic cross clamp time (90 ± 29.2 and 85 ± 32.0 min, p = 0.464), cardiopulmonary bypass time (125 ± 31.9 and 116 ± 38.5 min, p = 0.568), and operation time (206 ± 41.0 and 217 ± 60.0 min, p = 0.389). Post ablation treatment with antiarrhythmic drugs or betablockers was similar in both groups (Table [3](#T3){ref-type="table"}). In 6 patients, a dual chamber pacemaker was implanted due to sinus node dysfunction. Regarding perioperative morbidity, the incidence of heart failure requiring intraaortic balloon pump support and the incidence of renal failure was significantly higher in octogenarians. All patients of this group who acquired infections early after operation developed sepsis. The incidence of cerebral ischemic events was similar in younger and older patients. Overall, 2 strokes (on postoperative day \[POD\] 1 and 5), and 2 transient neurological deficits (on POD 2 and 6) occurred. Multiple thrombembolism due to hereditary thrombotic thrombocytopenic purpura occurred in one of these patients on POD 5. Apart from a trend to prolonged mechanical ventilation, older age was associated with significantly longer ICU and hospital stay. Perioperative mortality was higher in octogenarians. No death was ablation related.

###### 

Perioperative data

                                            Age \< 80 yrs (n = 172)   Age ≥ 80 yrs (n = 28)   p
  -------------------------------- -------- ------------------------- ----------------------- -------
  betablocker                      \% (n)   27.9 (48)                 17.8 (5)                0.172
  class III antiarrhythmic drugs   \% (n)   52.3 (90)                 60.7 (17)               0.409
   Sotalol                         \% (n)   76.7 (69)                 58.8 (10)               0.125
   Amiodaron                       \% (n)   23.3 (21)                 41.2 (7)                0.125
  DC shock cardioversion           \% (n)   4.6 (8)                   3.6 (1)                 0.798
  pacemaker implantation           \% (n)   3.5 (6)                   \-                      \-
  re-exploration for bleeding      \% (n)   2.3 (4)                   \-                      \-
  pericardial effusion             \% (n)   1.2 (2)                   \-                      \-
  heart failure                    \% (n)   4.1 (7)                   7.1 (2)                 0.467
   inotropic support               \% (n)   4.1 (7)                   7.1 (2)                 0.467
   IABP                            \% (n)   2.9 (5)                   5.1 (4)                 0.045
   LVAD                            \% (n)   1.2 (2)                   \-                      \-
  pulmonary failure                \% (n)   \-                        3.6 (1)                 \-
  renal failure                    \% (n)   7.0 (12)                  17.8 (5)                0.056
  cerebrovascular accident         \% (n)   1.7 (3)                   3.6 (1)                 0.522
  intracerebral hemorrhage         \% (n)   0.6 (1)                   \-                      \-
  infection                        \% (n)   4.6 (8)                   10.7 (3)                0.192
   mediastinitis                   \% (n)   0.6 (1)                   3.6 (1)                 0.140
   bronchopulmonary infection      \% (n)   4.1 (7)                   7.1 (2)                 0.467
   sepsis                          \% (n)   2.3 (4)                   10.7 (3)                0.025
  mechanical ventilation time      hrs      21 ± 50.3                 28 ± 41.1               0.069
  ICU stay                         days     4 ± 7.2                   8 ± 16.9                0.027
  hospital stay                    days     14 ± 30.8                 20 ± 23.9               0.004
  mortality (30 days)              \% (n)   4.6 (8)                   14.3 (4)                0.046
  cardiac death                    \% (n)   0.6 (1)                   3.6 (1)                 0.140
  non-cardiac death                \% (n)   4.1 (7)                   10.7 (3)                0.135

DC, direct current; IABP, intraaortic balloon pump; ICU, intensive care unit; LVAD, left ventricular assist device; yrs, years

Outcome during follow up
------------------------

Mean FU after 12 ± 6.1 months was 95% complete; 9 patients were lost. During FU, mortality was higher in octogenarians (16.7% versus 6.1%, p = 0.065). Causes of late death were cardiac in 3 and 1, non-cardiac in 6 and 2, and unknown in either 1 younger and older patients, respectively. In neither group, thrombembolic complications occurred. Compared to discharge, there was a trend to higher SR conversion rate after 6 and 12 months (Figure [1](#F1){ref-type="fig"}). Neither between cohorts, nor at different FU visits, statistical significance was reached. Results regarding rhythm outcome are outlined in Table [4](#T4){ref-type="table"}. At latest available FU, 14 octogenarians (82%) and 101 younger patients (68%, p = 0.231) were in sinus rhythm (SR); 59% without antiarrhythmic drugs in either group (p = 0.997). Recurrent tachyarrhythmia was successfully treated by DC shock cardioversion in 3 patients aged \< 80 years and 1 patient ≥ 80 years and by interventional ablation in 2 younger patients. The majority of patients in SR presented normal atrial contraction (Table [4](#T4){ref-type="table"}). Compared to patients who were not in SR, patients with restored SR at FU presented smaller LA size (41 ± 5.3 versus 45 ± 7.3 mm, p = 0.005 and 41 ± 8.8 versus 46 ± 11.6 mm, p = 0.498) and better NYHA functional class (1.8 ± 0.60 versus 2.2 ± 0.56, p \< 0.001 and 1.9 ± 0.48 versus 2.3 ± 0.58, p = 0.203) in younger and older age group, respectively. According to LVEF, left ventricular function remained unchanged in either group. Kaplan-Meier estimates of freedom from persistent AF demonstrated no difference between both groups (Figure [2](#F2){ref-type="fig"}).

###### 

Outcome at last follow up

                                 Age \< 80 yrs (n = 148)   Age ≥ 80 yrs (n = 17)   p
  --------------------- -------- ------------------------- ----------------------- -------
  sinus rhythm          \% (n)   68.2 (101)                82.3 (14)               0.231
   atrial contraction   \% (n)   87.8 (79)                 100 (12)                0.200
   E/A ratio                     2.5 ± 0.83                2.1 ± 0.75              0.179
  atrial fibrillation   \% (n)   26.3 (39)                 11.8 (2)                0.187
  atrial flutter        \% (n)   3.4 (5)                   5.9 (1)                 0.601
  NYHA class                     1.9 ± 0.61\*              2.1 ± 0.57\*            0.304
  LA diameter           mm       42 ± 6.3\*                42 ± 9.1\*              0.952
  LVEF                           0.52 ± 0.120^†^           0.55 ± 0.091\*          0.358
  LVEDD                 mm       54 ± 9.4^†^               49 ± 8.3^†^             0.048

\*p \< 0.001, comparison to preoperative data by Wilcoxon rank-sum test

^†^p = n.s., comparison to preoperative data by Wilcoxon rank-sum test

E/A ratio, ratio of maximal flow velocities of early (E) and atrial (A) diastolic transmitral flow signal assessed by pulsed-wave Doppler; NYHA, New York Heart Association; LA, left atrial; LVEF, left ventricular ejection fraction; LVEDD, left ventricular enddiastolic diameter

Assessment of LA function by pulsed wave Doppler failed in 11 and 2 patients in the younger and older age group, respectively.

![**Sinus rhythm at follow up**. Figures in bars indicate absolute frequencies of patients in SR.](1749-8090-3-21-1){#F1}

![**Kaplan-Meier estimates**. Freedom from persistent AF in patients \</≥ 80 years. AF, atrial fibrillation; yrs, years.](1749-8090-3-21-2){#F2}

Discussion
==========

A constant extension of life expectancy in industrialized countries together with an increased incidence of cardiovascular disease is leading to a rising number of elderly patients referred for cardiac surgery. These patients frequently present with AF, because the prevalence of this arrhythmia is exponentially age-related \[[@B6]\]. Whereas AF occurs in less than 0.5% of patients younger than 60 years, approximately 10% of patients older than 80 years are in AF \[[@B6]\]. Because promising results have been reported on valvular and coronary surgery in octogenarians \[[@B2]-[@B4]\], we evaluated the outcome of patients in this age group after concomitant AF ablation.

In this study, octogenarians were different from younger controls in that they were more likely to be female and require aortic valve replacement. Either distribution refers to demographic characteristics and is consistent with previous reports \[[@B15],[@B16]\]. On the other hand, the underlying heart disease does not determine results of AF ablation \[[@B7]\]. The observed inferior functional status according to NYHA class and the trend to higher incidence of preoperative thrombembolic events may reflect general findings in advanced age \[[@B2]\]. As age is one of the most important predictors for operative mortality \[[@B14]\], patients ≥ 80 years exhibited a significantly higher risk reflected by EuroSCORE. According to recent reports, early mortality after cardiac surgery in octogenarians ranges from 7.5% to 26.5% (table [5](#T5){ref-type="table"}). Apart from age, NYHA functional class \[[@B3],[@B17],[@B18]\], presence of heart failure as well as left ventricular dysfunction \[[@B3],[@B15]\], pulmonary hypertension \[[@B17]\], and renal insufficiency \[[@B3],[@B19]\] were demonstrated to be predictive factors for mortality. Furthermore, procedural factors as urgent/emergency and re-do surgery \[[@B3],[@B4],[@B18]-[@B20]\] or combined valvular plus revascularization surgery \[[@B4]\] increase operative risk. In this study, patients ≥ 80 years who died early after operation were characterized by LVEF ≤ 0.40 (n = 2), re-do surgery (n = 1), and other than isolated CABG (n = 4) resulting in a mean logistic EuroSCORE of 25.6%. Interestingly, causes of death were mainly non-cardiac. As reported very recently, AF per se seems to be a marker for higher operative risk \[[@B21],[@B22]\]. However, the particular impact of AF ablation on perioperative mortality has not been clarified, yet. Analysis of overall complications early after operation (table [3](#T3){ref-type="table"}) reflects the fragility of octogenarians due to age-related alterations in different organ systems. As in our patients for instance, renal failure frequently occurs after cardiac surgery in octogenarians \[[@B2],[@B19]\] and contributes to operative risk \[[@B20]\]. In contrast to others \[[@B2],[@B19],[@B20]\], we did not observe an increase in postoperative stroke in our small cohort of patients. With respect to mechanical ventilation time, length of ICU and hospital stay, and incidence of postoperative complications, increased resource utilization has to be considered in octogenarians undergoing cardiac surgery \[[@B2]\].

###### 

Outcome of octogenarians undergoing cardiac surgery

           procedure               author             year   n      operative mortality   longterm survival   
  -------- ----------------------- ------------------ ------ ------ --------------------- ------------------- -------
  CABG     isolated                Alexander \[19\]   2000   4306   8.1% (hospital)       \-                  \-
           isolated                Kolh \[18\]        2001   70     10.0% (hospital)      \-                  65.8%
           isolated                Scott \[2\]        2005   155    9.0% (30 days)        \-                  \-
                                                                                                              
  AVR      combined                Alexander \[19\]   2000   345    10.1% (hospital)      \-                  \-
           isolated and combined   Sundt \[20\]       2000   133    11.0% (30 days)       80.0%               55.0%
           isolated                Kolh \[18\]        2001   70     8.5% (hospital)       \-                  63.6%
           combined                Kolh \[18\]        2001   30     26.5% (hospital)      \-                  62.4%
           isolated and combined   Chiappini \[23\]   2004   115    8.5% (hospital)       86.4%               69.4%
           isolated and combined   Langanay \[3\]     2006   442    7.5%                  \-                  \-
                                                                                                              
  MVP-/R   combined                Alexander \[19\]   2000   92     19.7% (hospital)      \-                  \-
           isolated                Kolh \[18\]        2001   12     25.0% (hospital)                          57.1%
           isolated and combined   Nagendran \[4\]    2005   58     15.5% (hospital)      \-                  70.0%

AVR, aortic valve replacement; CABG, coronary artery bypass grafting; MVP-/R, mitral valve plasty/replacement

Overall survival of 82% after mean FU of 12 months was comparable with outcome after isolated or combined aortic valve replacement (table [5](#T5){ref-type="table"}) \[[@B20],[@B23]\]. As AF prevalence is high in patients older than 80 years \[[@B6]\], it seems obvious that advanced age predicted recurrent AF after the Cox Maze procedure in mitral valve disease \[[@B24]\]. Nonetheless, we found, that SR can be restored in the majority of elderly patients leading to normal atrial contraction and symptomatic improvement regarding NYHA functional class. Although octogenarians more frequently presented with paroxysmal AF at baseline, 71.4% of patients ≥ 80 years with persistent AF before operation were in SR at last FU. Moreover, freedom from AF during FU was not different in octogenarians and younger patients (figure [2](#F2){ref-type="fig"}). The overall SR conversion rate observed in this study is within the range of 57--92%, reported in a recent metaanalysis \[[@B25]\]. At least in part, this could be attributed to the left atrial in contrast to the classical biatrial approach. However, a less complex procedure for concomitant AF treatment might be beneficial, in particular for octogenarians. Furthermore, it was shown that AF will not recur if macro-reentry can be prevented by lesions critically placed in the left atrium \[[@B11],[@B13]\].

Conclusion
==========

This is the first report on concomitant AF ablation in octogenarians undergoing cardiac surgery. The main finding is, that SR and atrial transport function could be restored in the majority of patients. Certainly, ongoing research has to prove these results in larger cohorts and during long-term follow up. Because this study is a retrospective analysis of prospectively collected data it suffers from general limitations inherent to observational studies in non-randomized patient groups. Hence, we are unable to generalize our results to all patients ≥ 80 years with AF necessitating cardiac surgery. Preoperative identification of candidates in whom concomitant AF ablation will improve outcome is indeed challenging, especially if perioperative risk and a certain percentage of patients remaining in AF are considered. Nevertheless, our finding suggests integration of concomitant AF ablation as reasonable treatment strategy in elderly patients with AF referred for cardiac surgery.
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